PATENT

EP3689383

CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN

EPO Register

Applicant(s)

The U.S.A. as represented by the Secretary, Department of Health and Human Services, The United States Of America, As Represented By The Secretary, Department of Health and Human Services

Status

The patent has been granted

Status date

2025-11-28

Opposition filed

2026-01-09

Latest register event

2026-10-11

Family

48045750

Source: EPO Open Patent Services (epo-ops).

Court proceedings (3)

🇪🇺 UPCUPC_CFI_29/2026Brussels Local Division
2026-09-23
2seventy bio, Inc. v. Johnson & Johnson, Janssen Pharmaceuticals Inc. +16
infringementEP36893831 document
🇪🇺 UPCUPC_CFI_2192/2026Brussels Local Division
2026-07-23
TER MEER STEINMEISTER & PARTNER PATENTANWÄLTE MBB, TER MEER STEINMEISTER & PARTNER +12 v. INC. (2) JOHNSON & JOHNSON (3) JANSSEN BIOTECH, The Claimant’s Statement of Claim relating to claim construction +14
proceduralEP36893831 document
🇪🇺 UPCUPC_CFI_1934/2026Brussels Local Division
2026-06-08
Establishment Labs S.A., 2SEVENTY BIO, INC. v. S.L.U. GC Aesthetics GmbH GC Aesthetics Holdings Limited GC Aesthetics Finance Limited Romed NV, JANSSEN BIOTECH, INC. +11
revocationEP36893831 document